MRT (TSE:6034) ROCE % : -8.48% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is MRT ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MRT's annualized ROCE % for the quarter that ended in Mar. 2024 was -8.48%.

MRT ROCE % Historical Data

The historical data trend for MRT's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MRT ROCE % Chart

MRT Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

3.62

8.02

10.92

48.11

76.17

MRT Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															35.58	30.45	11.65	-8.00	-8.48

MRT ROCE % Calculation

MRT's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	2978.731	/	( ( (4983.633 - 2121.023)	+	(8159.023 - 3200.163) )	/ 2 )
	=	2978.731	/	( (2862.61	+	4958.86)	/ 2 )
	=	2978.731	/	3910.735
	=	76.17 %

MRT's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-429.848	/	( ( (6471.962 - 1375.05)	+	(6353.37 - 1306.846) )	/ 2 )
	=	-429.848	/	( ( 5096.912	+	5046.524 )	/ 2 )
	=	-429.848	/	5071.718
	=	-8.48 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

MRT (TSE:6034) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MRT ROCE % Related Terms

Thank you for viewing the detailed overview of MRT's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MRT (TSE:6034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MRT Inc (TSE:6034) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-18-2 Kanan, 3rd Floor, Frame Kananzaka, Shibuya-ku, Tokyo, JPN, 150-0041

Website

https://medrt.co.jp

MRT Inc engages in the business of medical personnel placement services through Internet. It provides part-time and full-time physician referral services through physician referral site MedRT.com; as well as part-time job referral; job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.

MRT (TSE:6034) Headlines

No Headlines